Stockholm - Delayed Quote SEK
ODI Pharma AB (ODI.ST)
2.5800
0.0000
(0.00%)
At close: April 25 at 9:00:00 AM GMT+2
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
21,500.5350
22,285.7090
139.4570
312.9380
--
Cost of Revenue
17,133.1480
17,664.4940
857.8150
416.5750
--
Gross Profit
4,367.3870
4,621.2150
-718.3580
-103.6370
--
Operating Expense
7,350.1370
4,193.1290
6,093.0050
7,103.2640
3,964.2480
Operating Income
-2,982.7500
428.0860
-6,811.3630
-7,206.9010
-3,964.2480
Net Non Operating Interest Income Expense
-858.1630
-807.5560
-83.7560
-28.6290
-3.0760
Pretax Income
-3,840.9140
-379.4700
-6,895.1190
-7,235.5300
-3,967.3240
Tax Provision
188.6010
188.5890
6.0170
3.5080
14.3720
Net Income Common Stockholders
-4,029.5150
-568.0590
-6,901.1360
-7,239.0380
-3,981.6960
Diluted NI Available to Com Stockholders
-4,029.5150
-568.0590
-6,901.1360
-7,239.0380
-3,981.6960
Basic EPS
-0.24
-0.02
-0.45
-0.48
-0.26
Diluted EPS
-0.24
-0.02
-0.45
-0.48
-0.26
Basic Average Shares
15,915.0340
15,248.4350
15,364.5100
15,109.5050
15,342.8270
Diluted Average Shares
15,915.0340
15,248.4350
15,364.5100
15,109.5050
15,342.8270
Total Operating Income as Reported
-2,982.7500
428.0860
-6,811.3630
-7,206.9010
-3,964.2480
Total Expenses
24,483.2850
21,857.6230
6,950.8200
7,519.8390
3,964.2480
Net Income from Continuing & Discontinued Operation
-4,029.5150
-568.0590
-6,901.1360
-7,239.0380
-3,981.6960
Normalized Income
-4,029.5150
-568.0590
-6,901.1360
-7,239.0380
-3,981.6960
Interest Income
66.9970
47.4620
23.9120
0.1330
11.4900
Interest Expense
925.1600
855.0180
107.6680
28.7620
14.5660
Net Interest Income
-858.1630
-807.5560
-83.7560
-28.6290
-3.0760
EBIT
-2,915.7540
475.5480
-6,787.4510
-7,206.7680
-3,952.7580
EBITDA
-2,913.1270
478.6450
-6,783.3370
-7,201.1800
-3,945.7830
Reconciled Cost of Revenue
17,133.1480
17,664.4940
857.8150
416.5750
--
Reconciled Depreciation
2.6270
3.0970
4.1140
5.5880
6.9750
Net Income from Continuing Operation Net Minority Interest
-4,029.5150
-568.0590
-6,901.1360
-7,239.0380
-3,981.6960
Normalized EBITDA
-2,913.1270
478.6450
-6,783.3370
-7,201.1800
-3,945.7830
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
6/30/2021 - 1/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade